P1694: COST-EFFECTIVENESS OF AXICABTAGENE CILOLEUCEL VS. TISAGENLECLEUCEL FOR THE TREATMENT OF RELAPSED/REFRACTORY LARGE B-CELL LYMPHOMA: UPDATED SURVIVAL RESULTS FROM THE ZUMA-1 A...

por Oluwole, Olalekan, Ray, Markqayne, Davies, Neil, Bradford, Rory, Jones, Calum, Patel, Anik, Locke, Frederick
Publicado 2023